 | • レポートコード：MRC2Q12-02458 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、128ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：化学&材料 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、薬用大麻のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 薬用大麻のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 薬用大麻の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 薬用大麻のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの薬用大麻の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の薬用大麻の売上および2028年までの予測に焦点を当てています。 薬用大麻のグローバル主要企業には、Ultra Health、Mammoth Farms、Palo Verde Center、Hexo Corp、Bright Green Corporation、Copperstate Farms、Los Suenos Farms、Canna、Village Farms、Aurora、Canopy Growth、Cresco Labs、Glass House Farms、Organigram、C3 International、CannTrust、FlowerOne、Solaris Farms、7Acres、ThePharmなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 薬用大麻市場は、タイプとアプリケーションによって区分されます。世界の薬用大麻市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 ドロナビノール、ナビロン、ナビキシモル、カンナビジオール、その他 【アプリケーション別セグメント】 病院、クリニック、薬局 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 薬用大麻製品概要 - タイプ別市場（ドロナビノール、ナビロン、ナビキシモル、カンナビジオール、その他） - アプリケーション別市場（病院、クリニック、薬局） - 調査の目的 ・エグゼクティブサマリー - 世界の薬用大麻販売量予測2017-2028 - 世界の薬用大麻売上予測2017-2028 - 薬用大麻の地域別販売量 - 薬用大麻の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別薬用大麻販売量 - 主要メーカー別薬用大麻売上 - 主要メーカー別薬用大麻価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（ドロナビノール、ナビロン、ナビキシモル、カンナビジオール、その他） - 薬用大麻のタイプ別販売量 - 薬用大麻のタイプ別売上 - 薬用大麻のタイプ別価格 ・アプリケーション別市場規模（病院、クリニック、薬局） - 薬用大麻のアプリケーション別販売量 - 薬用大麻のアプリケーション別売上 - 薬用大麻のアプリケーション別価格 ・北米市場 - 北米の薬用大麻市場規模（タイプ別、アプリケーション別） - 主要国別の薬用大麻市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの薬用大麻市場規模（タイプ別、アプリケーション別） - 主要国別の薬用大麻市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の薬用大麻市場規模（タイプ別、アプリケーション別） - 主要国別の薬用大麻市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の薬用大麻市場規模（タイプ別、アプリケーション別） - 主要国別の薬用大麻市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの薬用大麻市場規模（タイプ別、アプリケーション別） - 主要国別の薬用大麻市場規模（トルコ、サウジアラビア） ・企業情報 Ultra Health、Mammoth Farms、Palo Verde Center、Hexo Corp、Bright Green Corporation、Copperstate Farms、Los Suenos Farms、Canna、Village Farms、Aurora、Canopy Growth、Cresco Labs、Glass House Farms、Organigram、C3 International、CannTrust、FlowerOne、Solaris Farms、7Acres、ThePharm ・産業チェーン及び販売チャネル分析 - 薬用大麻の産業チェーン分析 - 薬用大麻の原材料 - 薬用大麻の生産プロセス - 薬用大麻の販売及びマーケティング - 薬用大麻の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 薬用大麻の産業動向 - 薬用大麻のマーケットドライバー - 薬用大麻の課題 - 薬用大麻の阻害要因 ・主な調査結果 |
Cannabis is a drug made from the cannabis plant, which is considered a medical drug in countries where it is legalized. It is made by drying the flowers and trichomes of female marijuana. It is mainly divided into three cultivars of common cannabis Indian cannabis and hybrid cannabis that combine the characteristics of the two. Its main effect is on the mental side, the main ingredient is THC, and cannabis also contains more than 423 known compounds, including at least 65 other cannabinoids, such as cannabidiol, cannabidiol, and their sensory effects There is a clear difference in the psychoactive effects produced by THC. The term Marijuana refers to cannabis in herbal form, including mature female flowers, leaves, and stems, while Hashish refers to cannabis resin, a way of concentrating cannabis.
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Medicinal Grade Cannabis estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Medicinal Grade Cannabis is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Medicinal Grade Cannabis is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Medicinal Grade Cannabis is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Medicinal Grade Cannabis include Ultra Health, Mammoth Farms, Palo Verde Center, Hexo Corp, Bright Green Corporation, Copperstate Farms, Los Suenos Farms, Canna and Village Farms, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
In terms of production side, this report researches the Medicinal Grade Cannabis production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of sales side, this report focuses on the sales of Medicinal Grade Cannabis by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
Report Scope
This latest report researches the industry structure, capacity, production, sales (consumption), revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Medicinal Grade Cannabis manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Medicinal Grade Cannabis market. Further, it explains the major drivers and regional dynamics of the global Medicinal Grade Cannabis market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Ultra Health
Mammoth Farms
Palo Verde Center
Hexo Corp
Bright Green Corporation
Copperstate Farms
Los Suenos Farms
Canna
Village Farms
Aurora
Canopy Growth
Cresco Labs
Glass House Farms
Organigram
C3 International
CannTrust
FlowerOne
Solaris Farms
7Acres
ThePharm
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on production, price, and value for the period 2017-2028.
Medicinal Grade Cannabis Segment by Type
Dronabinol
Nabilone
Nabiximols
Cannabidiol
Other
Medicinal Grade Cannabis Segment by Application
Hospital
Clinic
Pharmacy
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. This report analyzes the Medicinal Grade Cannabis production by region/country, and the sales (consumption) by region/country. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Medicinal Grade Cannabis market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Medicinal Grade Cannabis, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Medicinal Grade Cannabis, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Medicinal Grade Cannabis, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Medicinal Grade Cannabis sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Medicinal Grade Cannabis market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Medicinal Grade Cannabis sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Ultra Health, Mammoth Farms, Palo Verde Center, Hexo Corp, Bright Green Corporation, Copperstate Farms, Los Suenos Farms, Canna and Village Farms, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Medicinal Grade Cannabis capacity, production/output of global and key producers (regions/countries). It provides a quantitative analysis of the capacity, production, and development potential of each producer in the next six years.
Chapter 3: Sales (consumption), revenue of Medicinal Grade Cannabis in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Medicinal Grade Cannabis manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: North America by type, by application and by country, sales and revenue for each segment.
Chapter 8: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 9: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 10: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 11: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Medicinal Grade Cannabis sales, revenue, price, gross margin, and recent development, etc.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 15: The main points and conclusions of the report.
1 Study Coverage
1.1 Medicinal Grade Cannabis Product Introduction
1.2 Market by Type
1.2.1 Global Medicinal Grade Cannabis Market Size by Type, 2017 VS 2021 VS 2028
1.2.2 Dronabinol
1.2.3 Nabilone
1.2.4 Nabiximols
1.2.5 Cannabidiol
1.2.6 Other
1.3 Market by Application
1.3.1 Global Medicinal Grade Cannabis Market Size by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Pharmacy
1.4 Study Objectives
1.5 Years Considered
2 Global Medicinal Grade Cannabis Production
2.1 Global Medicinal Grade Cannabis Production Capacity (2017-2028)
2.2 Global Medicinal Grade Cannabis Production by Region: 2017 VS 2021 VS 2028
2.3 Global Medicinal Grade Cannabis Production by Region
2.3.1 Global Medicinal Grade Cannabis Historic Production by Region (2017-2022)
2.3.2 Global Medicinal Grade Cannabis Forecasted Production by Region (2023-2028)
2.4 North America
2.5 Europe
2.6 China
2.7 Japan
3 Global Medicinal Grade Cannabis Sales in Volume & Value Estimates and Forecasts
3.1 Global Medicinal Grade Cannabis Sales Estimates and Forecasts 2017-2028
3.2 Global Medicinal Grade Cannabis Revenue Estimates and Forecasts 2017-2028
3.3 Global Medicinal Grade Cannabis Revenue by Region: 2017 VS 2021 VS 2028
3.4 Global Medicinal Grade Cannabis Sales by Region
3.4.1 Global Medicinal Grade Cannabis Sales by Region (2017-2022)
3.4.2 Global Sales Medicinal Grade Cannabis by Region (2023-2028)
3.5 Global Medicinal Grade Cannabis Revenue by Region
3.5.1 Global Medicinal Grade Cannabis Revenue by Region (2017-2022)
3.5.2 Global Medicinal Grade Cannabis Revenue by Region (2023-2028)
3.6 North America
3.7 Europe
3.8 Asia-Pacific
3.9 Latin America
3.10 Middle East & Africa
4 Competition by Manufactures
4.1 Global Medicinal Grade Cannabis Production Capacity by Manufacturers
4.2 Global Medicinal Grade Cannabis Sales by Manufacturers
4.2.1 Global Medicinal Grade Cannabis Sales by Manufacturers (2017-2022)
4.2.2 Global Medicinal Grade Cannabis Sales Market Share by Manufacturers (2017-2022)
4.2.3 Global Top 10 and Top 5 Largest Manufacturers of Medicinal Grade Cannabis in 2021
4.3 Global Medicinal Grade Cannabis Revenue by Manufacturers
4.3.1 Global Medicinal Grade Cannabis Revenue by Manufacturers (2017-2022)
4.3.2 Global Medicinal Grade Cannabis Revenue Market Share by Manufacturers (2017-2022)
4.3.3 Global Top 10 and Top 5 Companies by Medicinal Grade Cannabis Revenue in 2021
4.4 Global Medicinal Grade Cannabis Sales Price by Manufacturers
4.5 Analysis of Competitive Landscape
4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
4.5.2 Global Medicinal Grade Cannabis Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5.3 Global Medicinal Grade Cannabis Manufacturers Geographical Distribution
4.6 Mergers & Acquisitions, Expansion Plans
5 Market Size by Type
5.1 Global Medicinal Grade Cannabis Sales by Type
5.1.1 Global Medicinal Grade Cannabis Historical Sales by Type (2017-2022)
5.1.2 Global Medicinal Grade Cannabis Forecasted Sales by Type (2023-2028)
5.1.3 Global Medicinal Grade Cannabis Sales Market Share by Type (2017-2028)
5.2 Global Medicinal Grade Cannabis Revenue by Type
5.2.1 Global Medicinal Grade Cannabis Historical Revenue by Type (2017-2022)
5.2.2 Global Medicinal Grade Cannabis Forecasted Revenue by Type (2023-2028)
5.2.3 Global Medicinal Grade Cannabis Revenue Market Share by Type (2017-2028)
5.3 Global Medicinal Grade Cannabis Price by Type
5.3.1 Global Medicinal Grade Cannabis Price by Type (2017-2022)
5.3.2 Global Medicinal Grade Cannabis Price Forecast by Type (2023-2028)
6 Market Size by Application
6.1 Global Medicinal Grade Cannabis Sales by Application
6.1.1 Global Medicinal Grade Cannabis Historical Sales by Application (2017-2022)
6.1.2 Global Medicinal Grade Cannabis Forecasted Sales by Application (2023-2028)
6.1.3 Global Medicinal Grade Cannabis Sales Market Share by Application (2017-2028)
6.2 Global Medicinal Grade Cannabis Revenue by Application
6.2.1 Global Medicinal Grade Cannabis Historical Revenue by Application (2017-2022)
6.2.2 Global Medicinal Grade Cannabis Forecasted Revenue by Application (2023-2028)
6.2.3 Global Medicinal Grade Cannabis Revenue Market Share by Application (2017-2028)
6.3 Global Medicinal Grade Cannabis Price by Application
6.3.1 Global Medicinal Grade Cannabis Price by Application (2017-2022)
6.3.2 Global Medicinal Grade Cannabis Price Forecast by Application (2023-2028)
7 North America
7.1 North America Medicinal Grade Cannabis Market Size by Type
7.1.1 North America Medicinal Grade Cannabis Sales by Type (2017-2028)
7.1.2 North America Medicinal Grade Cannabis Revenue by Type (2017-2028)
7.2 North America Medicinal Grade Cannabis Market Size by Application
7.2.1 North America Medicinal Grade Cannabis Sales by Application (2017-2028)
7.2.2 North America Medicinal Grade Cannabis Revenue by Application (2017-2028)
7.3 North America Medicinal Grade Cannabis Sales by Country
7.3.1 North America Medicinal Grade Cannabis Sales by Country (2017-2028)
7.3.2 North America Medicinal Grade Cannabis Revenue by Country (2017-2028)
7.3.3 United States
7.3.4 Canada
8 Europe
8.1 Europe Medicinal Grade Cannabis Market Size by Type
8.1.1 Europe Medicinal Grade Cannabis Sales by Type (2017-2028)
8.1.2 Europe Medicinal Grade Cannabis Revenue by Type (2017-2028)
8.2 Europe Medicinal Grade Cannabis Market Size by Application
8.2.1 Europe Medicinal Grade Cannabis Sales by Application (2017-2028)
8.2.2 Europe Medicinal Grade Cannabis Revenue by Application (2017-2028)
8.3 Europe Medicinal Grade Cannabis Sales by Country
8.3.1 Europe Medicinal Grade Cannabis Sales by Country (2017-2028)
8.3.2 Europe Medicinal Grade Cannabis Revenue by Country (2017-2028)
8.3.3 Germany
8.3.4 France
8.3.5 U.K.
8.3.6 Italy
8.3.7 Russia
9 Asia Pacific
9.1 Asia Pacific Medicinal Grade Cannabis Market Size by Type
9.1.1 Asia Pacific Medicinal Grade Cannabis Sales by Type (2017-2028)
9.1.2 Asia Pacific Medicinal Grade Cannabis Revenue by Type (2017-2028)
9.2 Asia Pacific Medicinal Grade Cannabis Market Size by Application
9.2.1 Asia Pacific Medicinal Grade Cannabis Sales by Application (2017-2028)
9.2.2 Asia Pacific Medicinal Grade Cannabis Revenue by Application (2017-2028)
9.3 Asia Pacific Medicinal Grade Cannabis Sales by Region
9.3.1 Asia Pacific Medicinal Grade Cannabis Sales by Region (2017-2028)
9.3.2 Asia Pacific Medicinal Grade Cannabis Revenue by Region (2017-2028)
9.3.3 China
9.3.4 Japan
9.3.5 South Korea
9.3.6 India
9.3.7 Australia
9.3.8 China Taiwan
9.3.9 Indonesia
9.3.10 Thailand
9.3.11 Malaysia
10 Latin America
10.1 Latin America Medicinal Grade Cannabis Market Size by Type
10.1.1 Latin America Medicinal Grade Cannabis Sales by Type (2017-2028)
10.1.2 Latin America Medicinal Grade Cannabis Revenue by Type (2017-2028)
10.2 Latin America Medicinal Grade Cannabis Market Size by Application
10.2.1 Latin America Medicinal Grade Cannabis Sales by Application (2017-2028)
10.2.2 Latin America Medicinal Grade Cannabis Revenue by Application (2017-2028)
10.3 Latin America Medicinal Grade Cannabis Sales by Country
10.3.1 Latin America Medicinal Grade Cannabis Sales by Country (2017-2028)
10.3.2 Latin America Medicinal Grade Cannabis Revenue by Country (2017-2028)
10.3.3 Mexico
10.3.4 Brazil
10.3.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Medicinal Grade Cannabis Market Size by Type
11.1.1 Middle East and Africa Medicinal Grade Cannabis Sales by Type (2017-2028)
11.1.2 Middle East and Africa Medicinal Grade Cannabis Revenue by Type (2017-2028)
11.2 Middle East and Africa Medicinal Grade Cannabis Market Size by Application
11.2.1 Middle East and Africa Medicinal Grade Cannabis Sales by Application (2017-2028)
11.2.2 Middle East and Africa Medicinal Grade Cannabis Revenue by Application (2017-2028)
11.3 Middle East and Africa Medicinal Grade Cannabis Sales by Country
11.3.1 Middle East and Africa Medicinal Grade Cannabis Sales by Country (2017-2028)
11.3.2 Middle East and Africa Medicinal Grade Cannabis Revenue by Country (2017-2028)
11.3.3 Turkey
11.3.4 Saudi Arabia
11.3.5 UAE
12 Corporate Profiles
12.1 Ultra Health
12.1.1 Ultra Health Corporation Information
12.1.2 Ultra Health Overview
12.1.3 Ultra Health Medicinal Grade Cannabis Sales, Price, Revenue and Gross Margin (2017-2022)
12.1.4 Ultra Health Medicinal Grade Cannabis Product Model Numbers, Pictures, Descriptions and Specifications
12.1.5 Ultra Health Recent Developments
12.2 Mammoth Farms
12.2.1 Mammoth Farms Corporation Information
12.2.2 Mammoth Farms Overview
12.2.3 Mammoth Farms Medicinal Grade Cannabis Sales, Price, Revenue and Gross Margin (2017-2022)
12.2.4 Mammoth Farms Medicinal Grade Cannabis Product Model Numbers, Pictures, Descriptions and Specifications
12.2.5 Mammoth Farms Recent Developments
12.3 Palo Verde Center
12.3.1 Palo Verde Center Corporation Information
12.3.2 Palo Verde Center Overview
12.3.3 Palo Verde Center Medicinal Grade Cannabis Sales, Price, Revenue and Gross Margin (2017-2022)
12.3.4 Palo Verde Center Medicinal Grade Cannabis Product Model Numbers, Pictures, Descriptions and Specifications
12.3.5 Palo Verde Center Recent Developments
12.4 Hexo Corp
12.4.1 Hexo Corp Corporation Information
12.4.2 Hexo Corp Overview
12.4.3 Hexo Corp Medicinal Grade Cannabis Sales, Price, Revenue and Gross Margin (2017-2022)
12.4.4 Hexo Corp Medicinal Grade Cannabis Product Model Numbers, Pictures, Descriptions and Specifications
12.4.5 Hexo Corp Recent Developments
12.5 Bright Green Corporation
12.5.1 Bright Green Corporation Corporation Information
12.5.2 Bright Green Corporation Overview
12.5.3 Bright Green Corporation Medicinal Grade Cannabis Sales, Price, Revenue and Gross Margin (2017-2022)
12.5.4 Bright Green Corporation Medicinal Grade Cannabis Product Model Numbers, Pictures, Descriptions and Specifications
12.5.5 Bright Green Corporation Recent Developments
12.6 Copperstate Farms
12.6.1 Copperstate Farms Corporation Information
12.6.2 Copperstate Farms Overview
12.6.3 Copperstate Farms Medicinal Grade Cannabis Sales, Price, Revenue and Gross Margin (2017-2022)
12.6.4 Copperstate Farms Medicinal Grade Cannabis Product Model Numbers, Pictures, Descriptions and Specifications
12.6.5 Copperstate Farms Recent Developments
12.7 Los Suenos Farms
12.7.1 Los Suenos Farms Corporation Information
12.7.2 Los Suenos Farms Overview
12.7.3 Los Suenos Farms Medicinal Grade Cannabis Sales, Price, Revenue and Gross Margin (2017-2022)
12.7.4 Los Suenos Farms Medicinal Grade Cannabis Product Model Numbers, Pictures, Descriptions and Specifications
12.7.5 Los Suenos Farms Recent Developments
12.8 Canna
12.8.1 Canna Corporation Information
12.8.2 Canna Overview
12.8.3 Canna Medicinal Grade Cannabis Sales, Price, Revenue and Gross Margin (2017-2022)
12.8.4 Canna Medicinal Grade Cannabis Product Model Numbers, Pictures, Descriptions and Specifications
12.8.5 Canna Recent Developments
12.9 Village Farms
12.9.1 Village Farms Corporation Information
12.9.2 Village Farms Overview
12.9.3 Village Farms Medicinal Grade Cannabis Sales, Price, Revenue and Gross Margin (2017-2022)
12.9.4 Village Farms Medicinal Grade Cannabis Product Model Numbers, Pictures, Descriptions and Specifications
12.9.5 Village Farms Recent Developments
12.10 Aurora
12.10.1 Aurora Corporation Information
12.10.2 Aurora Overview
12.10.3 Aurora Medicinal Grade Cannabis Sales, Price, Revenue and Gross Margin (2017-2022)
12.10.4 Aurora Medicinal Grade Cannabis Product Model Numbers, Pictures, Descriptions and Specifications
12.10.5 Aurora Recent Developments
12.11 Canopy Growth
12.11.1 Canopy Growth Corporation Information
12.11.2 Canopy Growth Overview
12.11.3 Canopy Growth Medicinal Grade Cannabis Sales, Price, Revenue and Gross Margin (2017-2022)
12.11.4 Canopy Growth Medicinal Grade Cannabis Product Model Numbers, Pictures, Descriptions and Specifications
12.11.5 Canopy Growth Recent Developments
12.12 Cresco Labs
12.12.1 Cresco Labs Corporation Information
12.12.2 Cresco Labs Overview
12.12.3 Cresco Labs Medicinal Grade Cannabis Sales, Price, Revenue and Gross Margin (2017-2022)
12.12.4 Cresco Labs Medicinal Grade Cannabis Product Model Numbers, Pictures, Descriptions and Specifications
12.12.5 Cresco Labs Recent Developments
12.13 Glass House Farms
12.13.1 Glass House Farms Corporation Information
12.13.2 Glass House Farms Overview
12.13.3 Glass House Farms Medicinal Grade Cannabis Sales, Price, Revenue and Gross Margin (2017-2022)
12.13.4 Glass House Farms Medicinal Grade Cannabis Product Model Numbers, Pictures, Descriptions and Specifications
12.13.5 Glass House Farms Recent Developments
12.14 Organigram
12.14.1 Organigram Corporation Information
12.14.2 Organigram Overview
12.14.3 Organigram Medicinal Grade Cannabis Sales, Price, Revenue and Gross Margin (2017-2022)
12.14.4 Organigram Medicinal Grade Cannabis Product Model Numbers, Pictures, Descriptions and Specifications
12.14.5 Organigram Recent Developments
12.15 C3 International
12.15.1 C3 International Corporation Information
12.15.2 C3 International Overview
12.15.3 C3 International Medicinal Grade Cannabis Sales, Price, Revenue and Gross Margin (2017-2022)
12.15.4 C3 International Medicinal Grade Cannabis Product Model Numbers, Pictures, Descriptions and Specifications
12.15.5 C3 International Recent Developments
12.16 CannTrust
12.16.1 CannTrust Corporation Information
12.16.2 CannTrust Overview
12.16.3 CannTrust Medicinal Grade Cannabis Sales, Price, Revenue and Gross Margin (2017-2022)
12.16.4 CannTrust Medicinal Grade Cannabis Product Model Numbers, Pictures, Descriptions and Specifications
12.16.5 CannTrust Recent Developments
12.17 FlowerOne
12.17.1 FlowerOne Corporation Information
12.17.2 FlowerOne Overview
12.17.3 FlowerOne Medicinal Grade Cannabis Sales, Price, Revenue and Gross Margin (2017-2022)
12.17.4 FlowerOne Medicinal Grade Cannabis Product Model Numbers, Pictures, Descriptions and Specifications
12.17.5 FlowerOne Recent Developments
12.18 Solaris Farms
12.18.1 Solaris Farms Corporation Information
12.18.2 Solaris Farms Overview
12.18.3 Solaris Farms Medicinal Grade Cannabis Sales, Price, Revenue and Gross Margin (2017-2022)
12.18.4 Solaris Farms Medicinal Grade Cannabis Product Model Numbers, Pictures, Descriptions and Specifications
12.18.5 Solaris Farms Recent Developments
12.19 7Acres
12.19.1 7Acres Corporation Information
12.19.2 7Acres Overview
12.19.3 7Acres Medicinal Grade Cannabis Sales, Price, Revenue and Gross Margin (2017-2022)
12.19.4 7Acres Medicinal Grade Cannabis Product Model Numbers, Pictures, Descriptions and Specifications
12.19.5 7Acres Recent Developments
12.20 ThePharm
12.20.1 ThePharm Corporation Information
12.20.2 ThePharm Overview
12.20.3 ThePharm Medicinal Grade Cannabis Sales, Price, Revenue and Gross Margin (2017-2022)
12.20.4 ThePharm Medicinal Grade Cannabis Product Model Numbers, Pictures, Descriptions and Specifications
12.20.5 ThePharm Recent Developments
13 Industry Chain and Sales Channels Analysis
13.1 Medicinal Grade Cannabis Industry Chain Analysis
13.2 Medicinal Grade Cannabis Key Raw Materials
13.2.1 Key Raw Materials
13.2.2 Raw Materials Key Suppliers
13.3 Medicinal Grade Cannabis Production Mode & Process
13.4 Medicinal Grade Cannabis Sales and Marketing
13.4.1 Medicinal Grade Cannabis Sales Channels
13.4.2 Medicinal Grade Cannabis Distributors
13.5 Medicinal Grade Cannabis Customers
14 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
14.1 Medicinal Grade Cannabis Industry Trends
14.2 Medicinal Grade Cannabis Market Drivers
14.3 Medicinal Grade Cannabis Market Challenges
14.4 Medicinal Grade Cannabis Market Restraints
15 Key Finding in The Global Medicinal Grade Cannabis Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer